Back to search
FDAFDA · Food and drugs·Recall number D-0534-2023

Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-475-60.

Published April 5, 2023 · Recall initiated: March 14, 2023

Summary

FDA records drug Class II recall D-0534-2023, published April 5, 2023 and initiated March 14, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 12,804 bottles; Lot: Lot #s: 22142448, 22142449, 22142450, Exp 5/2024; 22143845, Exp 7/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

What to do

Voluntary: Firm initiated · Letter

Get an email if DABIGATRAN ETEXILATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DABIGATRAN ETEXILATE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA.
UPC
0367877624600
Lot
Lot #s: 22142448, 22142449, 22142450, Exp 5/2024; 22143845, Exp 7/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-475-60. recalled?

Yes. FDA published recall D-0534-2023 on April 5, 2023. Reported hazard: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DABIGATRAN ETEXILATE. UPC: 0367877624600.